MedlinePlus: Nirsevimab-alip

• 2024

  Log in to bookmark this resource.

  Log in

---

Access Resources

• SummaryEN
• SummaryES
• Ask aRCie About This Resource

About

This webpage provides drug information on nirsevimab-alip (brand name: Beyfortus®). It addresses why and how it should be used, special precautions, and side effects.

---

Tags

Focus Area: Infectious Disease

Audience: Families & Children

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Infant; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Drug-Related Side Effects and Adverse Reactions; Antibodies, Monoclonal, Humanized

Institutions: American Society of Health-System Pharmacists (ASHP); U.S. Department of Health and Human Services (HHS)

---

More like this

Veterans Health Library: Nirsevimab-alip 2025 · American Society of Health-System Pharmacists (ASHP), U.S. Department of Veterans Affairs Protecting Children from Wildfire Smoke and Ash 2021 · American Academy of Pediatrics (AAP), Pediatric Environmental Health Specialty Units (PEHSU), U.S. Environmental Protection Agency, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM) National Assessment Highlights Impact of COVID-19 on Pediatric Capabilities of Emergency Departments – With Implications for Survival 2023 · Pediatric Pandemic Network (PPN)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---